ETFMG Treatments, Testing and Advancements ETF

GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.

Learn more
Image

ETFMG's First ETF SILJ Reaches $300M AUM Milestone

Launched November 2012, SILJ remains the first and only ETF providing direct exposure to the silver mining exploration and production industry.

Learn more
Image

Wedbush Announces Minority Stake in ETFMG

Wedbush Securities and ETF Managers Group (ETFMG) today announced that Wedbush has made a minority investment in ETFMG to support the continued growth of their innovative thematic ETF platform...

Read more
Image

ETFMG Extends Sponsorship of UFC Heavyweight

ETF Managers Group (ETFMG), an industry leader in bringing innovative thematic ETFs to market, has announced the extension of its headline-making partnership with powerhouse UFC heavyweight, Alexey Oleynik...

Read more
Image

Featured Funds

All Other Funds

IVES

Disruptive Tech

AUM $45,102,467

AWAY

Disruptive Tech

AUM $9,521,109

VALT

Core Strategy

AUM $101,837,601

AIEQ

Core Strategy

AUM $93,542,023

BDRY

Commodity

AUM $37,323,786

ETHO

Disruptive TechCore Strategy

AUM $89,031,479

HACK

Disruptive Tech

AUM $1,541,446,320

IPAY

Disruptive Tech

AUM $778,970,927

ITEQ

Disruptive Tech

AUM $117,943,796

RISE

Commodity

AUM $5,036,178

*AUM is based on closing prices from previous market day.


At ETFMG we turn portfolio management strategies into successful ETFs and drive the ongoing operations. Sam Masucci, CEO & Founder At ETFMG we turn portfolio management strategies into successful ETFs and drive the ongoing operations. Sam Masucci, Founder & CEO Sam Masucci signs the book before ringing the Closing Bell at the NYSE on March 26, 2019.

We have all the expertise and execution capabilities necessary for success in the ETF space within our organization.

Our in-house team covers everything from product issuance to portfolio management, marketing, wholesaling, legal and compliance, providing unrivaled quality control and direct access to all disciplines.

About us

75%FIRST TO MARKET PRODUCTS

$3.9BASSETS UNDER MANAGEMENT

Learn more about our funds and their respective sectors.

Financial Professionals Login

Log in Sign up

Fund news and articles delivered to your inbox

Follow us for the latest news and updates